SLC1A1 and myeloid sarcoma: Transfection of miR-26a in MO3-13 cells reduced SLC1A1 mRNA by 50% and protein 30%. In 20 patients with MS treated with INF-β, miR-26a levels were increased SLC1A1 mRNA was decreased